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Evaluation of a novel vascular graft with a distal bifurcation designed  
to reduce the development of intimal hyperplasia.  
Experimental study in a porcine aorta model
Robert Vlachovskya, Robert Staffaa, Martin Dvoraka, Michal Vlasinb, Marketa Hermanovac, Thomas O’Briend,  
Timothy McGloughlind
Objective. Abnormal haemodynamics is commonly agreed to be a major contributor to the development of distal 
anastomotic intimal hyperplasia. A new vascular graft design proposed by computational studies was used to dem-
onstrate its surgical feasibility and to compare it with the conventional graft in a porcine model.
Method. The device was used in 12 eight-month-old pigs, six received the new graft and six had a conventional graft. 
The proximal graft end was implanted into the aorta, the distal graft end was implanted into the iliac artery. The host 
artery was ligated in order to simulate occlusion. At 20 weeks after surgery the pigs were killed and the device was 
excised for histological and morphometric analysis. 
Results. In five experimental grafts the reconstruction was occluded due to thrombosis; only one prosthesis was pat-
ent showing a minimum of neointimal hyperplasia. In the control group too only three of the six grafts were patent. 
A histological analysis revealed, as the cause of occlusion, fibrous tissue overgrowth corresponding in structure to 
neointimal hyperplasia. Differences in the number of obliterations and in occlusion rates between the profiles of the 
two groups were evaluated using the median test (P<0.05). The results were not statistically significant.
Conclusion. Although mathematical modelling had shown significant haemodynamic benefits of a naturally bifurcated 
graft, our study did not confirm its superiority over conventionally used prostheses.
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INTRODUCTION
The long-term patency rates of synthetic femoral ar-
tery bypass grafts remain poor despite great efforts of 
graft producers and vascular surgeons. Previous studies 
have reported patency rates for above-knee grafts as low 
as 62% at 3 years and 46% at 5 years1-3. Abnormal junction 
haemodynamics, wall shear stress (WSS), suture line in-
jury and material mismatch are the most frequently men-
tioned factors responsible for graft failure.
There are several theories suggesting different roles 
for these factors in typical distal end-to-side anastomosis 
(ESA) and, even though discussions are still ongoing, ab-
normal haemodynamics is commonly agreed to be a ma-
jor contributor to the development of intimal hyperplasia 
at the junction. The abnormal geometric nature of a distal 
ESA creates abnormal haemodynamics (disturbed flow 
with its associated flow separation, stagnation, and recir-
culation regions) which contributes to the development of 
intimal hyperplasia by affecting endothelial cells4-6. Poor 
patency of prosthetic bypass grafts has resulted in concen-
trated efforts to improve available prosthetic materials. 
A great deal of attention has been focused on surgical 
modifications (using an interposition vein cuff or patch), 
materials and coatings, protein modifications, endothelial 
cell seeding, and nitric oxide modifications of the exist-
ing prosthetic grafts to improve graft patency and clinical 
outcomes. Most of these modifications are designed to 
improve thrombogenicity, to decrease the development 
of neointimal hyperplasia, and/or to improve host incor-
poration and healing. However, all these attempts have 
yielded limited results, leaving this issue open to further 
investigation7-35.
It has been discovered that flow patterns created by a 
typical ESA exert abnormal WSS distributions not com-
monly found in healthy arteries. Studies have shown that 
wall stress concentrations in the vicinity of an ESA suture 
line are significantly higher than those occuring at an end-
to-end anastomosis (EEA) and a healthy artery. Clinical 
data support these findings, with results suggesting that 
EEA gives higher patency rates than ESA (ref.36).
Identification of these principles and the results of 
previous studies led our collegues from the Centre for 
Applied Biomedical Engineering Research (University 
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of Limerick, Ireland) to propose a new natural bifurca-
tion bypass graft device - Lamda© graft - for the treatment 
of peripheral arterial occlusive disease. This device has 
replaced one ESA with two EEAs, using a streamlined 
bifurcating junction, and thus minimising haemodynamic 
disturbances leasing to the development of intimal hyper-
plasia. In addition, the new device provides the type of 
bifurcation naturally found in the vascular system37.
The preliminary evaluations were performed by the 
Centre for Applied Biomedical Engineering Research, 
University of Limerick in Ireland, using mathematical 
modelling and computer simulations involving compu-
tational fluid dynamics (CFD model). During the maxi-
mum pulse velocity (peak flow), this device streamlines 
the blood flow to such an extent as to reduce peak WSS 
magnitudes and WSS gradients in the host artery by 17% 
and 53%, respectively. Flow separation along the roof of 
the host artery distal to the toe is eliminated. During the 
decelerative phase of the velocity pulse wave, the peak 
WSS magnitudes and WSS gradients are further reduced 
by 58% and 86%, respectively, with a slightly smaller toe 
flow separation region37.
The objective of our study was to introduce this novel 
design, to demonstrate its surgical feasibility and to com-
pare it with the conventional ESA to confirm that distal 
anastomosis of a vascular graft can create a bifurcating 
flow and thus reduce the risk of intimal hyperplasia de-
velopment.
Fig. 1. Geometrical configuration of the experimental graft 
(normal straight bypass graft with a new distal bifurcation). 
Fig. 2. Experimental graft implantation schematic. Fig. 3. Conventional graft implantation schematic.
MATERIALS AND METHODS
The geometric configuration of the device is shown 
in Fig. 1. It consists of a normal straight bypass graft 
with a new distal bifurcation added to it. The dacron vas-
cular prosthesis is made of polyester filament yarn and 
is impregnated with collagen, the graft lumen diameter 
(experimental and conventional device) is 6 mm. 
During the whole study, the animals were fed, han-
dled and housed in accordance with the principles of the 
Animal Welfare Act. All procedures were carried out with 
the approval of the Ethics Committee of the University 
of Veterinary and Pharmaceutical Sciences in Brno (No. 
11/07). 
The device was implanted into 12 eight-month-old pigs 
(weight, 58.4 ± 0.7 kg). Six animals (experimental group) 
received the new graft device and six animals (control 
group) had a conventional straight vascular graft. The 
proximal graft end was implanted into the aorta (one 
ESA in both groups), with the distal graft end or ends 
implanted into the iliac artery (two EEAs in the ex-
perimental group, one ESA in the control group) (Fig. 
2 and 3). Anticoagulation therapy with unfractionated 
heparin (100 IU kg-1) was administered intravenously 
during the surgical procedure, and the host artery (be-
low the proximal anastomosis) was ligated with standard 
suture material in order to simulate arterial occlusion. 
Heparin was reversed with protamine sulfate. Following 
closure of all soft tissues and the skin, the animals were 
allowed to recover from anaesthesia. A prophylactic an-
tibiotic (Penicillin G) was given preoperatively and 24 h 
postoperatively (Fig. 4 and 5). The pigs fully recovered 
and were mobile until they were killed at 20 weeks (140 
days) postoperatively when they weighed approximately 
190 kg. In each of the animals killed, the device including 
the end sections of the aorta and iliac artery was excised 
for histological assessment and morphometric analysis; 
together with the end sections it was visually examined for 
the presence of all anastomoses and potential thrombosis 
and then fixed in 10% neutral-buffered formalin for 24 h. 
Transverse sections were taken at specified points near the 
distal anastomoses and embedded in paraffin, using stan-
dard tissue processing (Fig. 6 and 7). The tissue sections 
were stained with haematoxylin and eosin and examined 
by the histopathologist. 
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Fig. 4. Experimental graft after the implantation. 1 – proxi-
mal anastomosis, 2 – distal anastomosis (proximal graft leg), 
3 – distal anastomosis (distal graft leg).
Fig. 5. Conventional graft after the implantation (control 
group). 1 – proximal anastomosis, 2 – distal anastomosis.
Fig. 6. Experimental graft histology sections (distal anasto-
mosis). A-A: Random section through the junction (A1: distal 
graft leg, A2:proximal graft leg), B-B: 1 to 2 mm upstream from 
proximal junction EEA, C-C: 1 to 2 mm downstream from proxi-
mal junction EEA (proximal graft leg), D-D: 5 mm upstream 
from distal junction EEA (distal graft leg), E-E: 1 to 2mm down-
stream from distal junction EEA (distal host artery), F-F: 10mm 
downstream from distal junction EEA (distal host artery). EEA 
- end-to-end anastomosis.
Fig. 7. Conventional graft histology sections (distal anasto-
mosis). A-A: 1 to 2 mm upstream from heel of ESA (proximal 
host artery), B-B: Random section through the junction (B1: 
graft, B2: native artery), C-C: 1 to 2 mm downstream from toe 
of ESA (distal host artery), D-D: 10mm downstream from toe 
of ESA (distal host artery). ESA - end-to-side anastomosis.
RESULTS
Surgical implant assessment and histology
Five outflow arteries (profile E and F) in the experi-
mental group had thrombosis and three of six controls 
also had graft occlusion due to thrombosis.
In the experimental group, variable degrees of non-
significant stenosis (10% to 30%) of the junction (section 
Ae) due to fibrous tissue formation were revealed in four 
cases. Four total obliterations and one severe stenosis 
(95%) of the proximal host artery (Be) were observed. 
Only in one case the proximal host artery showed a mini-
mal degree of neointima (Fig. 8).
Severe stenosis involving 90% to 95% of the distal host 
artery lumen (Ee) was observed in four pigs , total occlu-
sion was seen in one and a 20% stenosis was also found 
in one pig (Fig. 9 and 10). Total occlusion in section Fe 
was observed in five of six cases. The histological find-
ings revealed a significant degree of neointima with focal 
disruption of the smooth muscle layer of the media in 
both the proximal and the distal host artery.
In the control group, significant stenosis of the junc-
tion (B2c) due to fibrous tissue overgrowth was revealed in 
all cases (Fig. 11). Variable degrees of significant stenosis 
(60% to 95%) were demontrated in sections Cc and Dc of 
the distal host artery, with a higher degree of neointima 
in location Dc . 
Statistical methods and analysis
The degrees of occlusion of the graft lumen in differ-
ent sections are expresed as percent of stenosis (Table 
1). The data were analysed using the median test (non-
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Fig. 8. Random section through the junction, experimental 
graft histology sections, location A-A (hematoxylin-eosin, origi-
nal magnification x 40). 1 – subtotal graft occlusion, 2 – residual 
lumen of the distal graft leg, 3 – partial graft occlusion.
Fig. 9. Representative section of the distal junction of the 
experimental graft, location C-C (proximal graft leg) with neo-
intima (hematoxylin-eosin, original magnification x 40). 1 – 
intimal hyperplasia, 2 – graft.
Fig. 10. Representative section of the distal junction of the ex-
perimental graft, location D-D (distal graft leg) with neointima 
(hematoxylin-eosin, original magnification x 40). 1 – intima, 
2 – intimal hyperplasia, 3 – smooth muscle layer.
Fig. 11. Random section through the junction, conventional 
graft histology sections, location B-B, fibrous tissue in the graft 
lumen (hematoxylin-eosin, original magnification x 40).
parametric test not assuming any concrete data distribu-
tion). The percentages of stenosis in the experimental 
(Ce,De, Ee and Fe) and the control group (Bc, B1c,Cc and 
Dc) were tested (Ce versus B1c, De versus Bc, De versus 
B1c, De versus B2c, Ee versus Cc, Fe versus Dc). The level 
of statistical significance was set at P<0.05. The testing 
of all sections (except section De/B2c) did not show any 
statistically significant differences between the experi-
mental and control groups (Table 2). For section De/B2c, 
the intervention effect (reduction in intimal hyperplasia 
development) was significantly lower in the experimental 
than the control group (P=0.021).
DISCUSSION
Mathematical modelling of the proposed graft sug-
gested that the streamlined nature of blood flow through 
the new junction results in less disturbed haemodynam-
ics within the host artery junction. Abnormal WSS mag-
nitudes and gradients were reduced, and a normal fully 
developed flow in the distal host artery occurred earlier 
than in conventional anastomoses. The proposed graft 
has a design that is relevant to increased patency rates of 
prosthetic femoral-popliteal bypass grafts. One drawback 
of the proposed mathematical model is in that flow recir-
culation and flow separation existing within the prosthesis 
itself were not taken into consideration.
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The porcine experimental model was used because of 
similarities between the human and pig haemocoagulation 
systems and endothelial injury response. We found a suit-
able site for implantation of the device in the aortoiliac 
bed. During implantation the diameter of the vessels 
complied with the graft diameter. We successfully liga-
tured the proximal host artery to simulate atherosclerotic 
blockage. The pigs were regularly observed and no special 
symptoms of graft occlusion were recorded. Postoperative 
eventration requiring surgery developed in one pig, and 
temporary paresis of the left hind leg was found in another 
pig; both were from the experimental group.
However, our study showed several limitations. First, 
the characteristics of blood flow created within the 
proposed graft and their effect on the development of 
thrombi were not described in the mathematical model, 
thus thrombus formation could not be fully understood 
and therefore possible to take into account or deal with in 
an experimental study. Second, dacron grafts were used 
in our study. Previous experimental studies have found 
that low WSS resulting from diverging graft sections can 
lead to increased intimal hyperplasia inside polytetrafluo-
roethylene grafts38. A similar situation may occur inside 
dacron grafts and therefore the use of this material is 
disputable. Third, as in any synthetic prosthesis, the graft 
used in our study did not provide any buffer for material 
mismatch between a stiff graft and the compliant artery. 
However, correcting abnormal haemodynamics in ESA 
is recognised as more important than the issue of mate-
rial mismatch. An idealisation of the model is the fourth 
limitation. Realistic anastomoses are variable in terms of 
anastomotic angles, out-of-plane curvatures, graft/artery 
calibers, flow rates, and lumen surfaces. Previous studies 
have found significant differences between idealised mod-
els and realistic ones37,38. Graft failure in our experimental 
group can be explained by graft kinking. A PTFE graft or 
an externally supported dacron graft should be able to 
maintain appropriate curvatures better than the dacron 
graft used in our study.
Fifth, the interval between device implantation and 
its explantation (20 weeks) was very long. Piglets grow 
very fast and their growth acceleration poses a serious 
problem. Within five months the pig multiplies its weigth 
and, at the time of graft explantation, our animals weighed 
about 190 kg. To handle a relatively large animal is compli-
cated and, in addition, noticeable changes in its anatomy 
and size occur due to intensive growth in its body cavity. 
These changes could also have influenced the results. 
From the surgical point of view, the device relies on 
two end-to-side anastomoses, which is surgically feasible, 
but requires good surgical skills and more time than does 
a conventional distal anastomosis. Also, there is an in-
creased risk of technical complications during the surgical 
procedure.
Table 1. Degrees of occlusion of the graft lumen in different sections of both groups.
Section (experimental group, n=6) Ae A1e A2e Be Ce De Ee Fe
Degree of occlusion (%)
P1 0 0 0 100 80 90 95 100
P2 0 0 0 100 0 0 20 40
P3 10 0 20 95 50 40 95 100
P4 30 30 30 100 70 70 90 100
P5 10 0 20 100 70 5 95 100
P6 5 0 10 5 0 0 100 100
Section (control group, n=6) Ac Bc B1c B2c Cc Dc
Degree of occlusion (%)
P7 95 35 0 75 60 95
P8 100 45 0 90 90 95
P9 90 55 30 80 90 90
P10 95 75 60 85 95 95
P11 95 45 20 70 70 85
P12 95 40 0 80 85 95
values are in percentage (%) of lumen stenosis round by 5%, P1-12- pigs, e - experimental group, c -control group
Table 2. Median test results.
Section (experimental) 
vs. Section (control)
Ce / B1c De / Bc De / B1c De / B2c Ee / Cc Fe / Dc
P 0.248 0.248 1 0.021* 0.221 0.387
P<0.05, *significant result, e - experimental group, c - control group
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Considering all limitations of the experimental de-
sign in this study, it can be concluded that, to establish 
the device efficacy, a shorter period of study (12 to 14 
weeks) and a larger size of animal group will be necessary. 
A more in-depth study should involve imaging scans of 
implanted grafts (CT angiography, magnetic resonance 
angiography) to specify the time of occlusion.
CONCLUSION
The results of this study did not provide sufficient 
evidence that the proposed device is suitable for in vivo 
application or that it improves patency rates by decreasing 
the development of intimal hyperplasia. Although math-
ematical modelling has shown significant haemodynamic 
benefits, this animal study did not confirm our assump-
tion, suggesting that this new graft design with a distal 
bifurcation probably has no prospects for being used in 
vascular reconstruction. Efforts to find an optimal type 
and geometry of ESA will continue.
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